Raymond James & Associates’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,200
Closed -$72.9K 3906
2024
Q1
$72.9K Buy
+10,200
New +$72.9K ﹤0.01% 3731